Author

T. Schumacher

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. J. R. Heck· 1 shared A. Jeko· 1 shared A. Velds· 1 shared B. Nicolet· 1 shared F. Loayza-Puch· 1 shared G. Bounova· 1 shared K. Bresser· 1 shared L. Fanchi· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. J. R. Heck

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Gene and protein sequence features augment HLA class I ligand predictions

K. Bresser, B. Nicolet, A. Jeko, W. Wu, F. Loayza-Puch, R. Agami, A. J. R. Heck, M. J. R. Wolkers, T. Schumacher

The paper evaluates gene and protein sequence features as predictors of HLA class I ligand presentation, showing they improve predictions comparable to experimental gene expression data.

bioRxiv · Sep 3, 2023Immunology

Lack of detectable neoantigen depletion in treatment-naive cancers

M. Slagter, L. Fanchi, M. M. van Buuren, A. Velds, G. Bounova, L. Wessels, T. Schumacher

This study investigates neoantigen depletion in treatment-naive human tumors using two novel methodologies, finding no statistically significant evidence for depletion after controlling for confounding factors.

bioRxiv · Jun 21, 2023 · PreprintCancer Biology